Back to announcement
20231213_BMHS_Laporan Hasil Pelaksanaan Konversi ESOP MSOP_31559380_lamp1.pdf
Other Text extracted BMHSSource file signed link, expires in 15 minutes
Extracted text 2
Page 1
bmhs
since 1973
Jakarta, 13 Desember 2023
No. : 611-K/PD/BMHS/X11/2023
Peri hal/Subject : Keterbukaan Informasi Hasil Pelaksanaan MESOP PT Bundamedik Tbk
("Perseroan") / Disclosure of Information on the Results of MESOP
Implementation of PT Bundamedik Tbk (the "Company")
Kepada Yth./To:
Otoritas Jasa Keuangan ("OJK")
Gedung Sumitro Djojohadikusumo
JI. Lapangan Banteng Timur No. 2-4
Jakarta Pusat — 10710
U.p./Attn.To Yth. Bapak I Gede Nyoman Yetna
Direktur Penilaian Perusahaan /
Director of Corporate Assessment
Dengan hormat / Yours faithfully,
Merujuk kepada Surat Perseroan Nomor 515- Referring to the Company Letter 515-
K/PD/BMHS/X/2023 tanggal 25 Oktober 2023 perihal K/PD/BMHS/X/2023 dated October 25 th, 2023
Keterbukaan Informasi Periode Pelaksanaan MESOP. regarding Disclosure of Information on the MESOP
Maka sehubungan dengan periode pelaksanaan Implementation Period. Then in accordance to the
Management and Employee Stock Option Program implementation period of the Management and
("MESOP") pada tanggal 1 November 2023 sampai Employee Stock Option Program ("MESOP") November
dengan tanggal 12 Desember 2023, dan sesuai dengan 1, 2023 to December 12th, 2023, and according to the
ketentuan yang diatur dalam Surat Edaran BEI Nomor provisions stipulated in 1DX Circular Letter Number SE-
SE-00002/BEI/03- 2020, maka dengan ini Perseroan 00002/BE1/03- 2020, the Company hereby submit
menyampaikan keterbukaan informasi terkait dengan information disclosure related to the results of MESOP
hasil pelaksanaan MESOP sebagai berikut: implementation are as follows:
No. Keterangan/Description Penjelasan/Explanation
1. Jumlah opsi yang telah dilaksanakan hak konversinya 0 nihil/none
dan jumlah saham baru yang telah diterbitkan/
The Number of options with conversion rights that
have been exercised and number of new shares issued
2. Jumlah opsi yang belum dilaksanakan dan masih 22.500.000 saham/shares
berlaku/
The number of options that have not been exercised
and are still valid
PT Bundamedik Tbk
11. Teuku Cik Ditiro No. 28
Menteng-Jakarta Pusat 10350, Indonesia
'c..+62 21 3192 3344 +62 21 3190 5915 ti www.bmhs.co.id
From Embryo Throughout Life
Page 2
N,
bmhs
1 ; since 19 7 3
3. Jumlah saham MESOP yang belum dilaksanakan dan 0 (nihil)/none
habis masa berlakunya/
The number of MESOP shares that have not been
exercised and expired
Demikian keterbukaan informasi ini kami sampaikan, atas perhatian dan kerjasamanya kami ucapkan terima
kasih./Hereby we convey this disclosure of information, thank you for your kind attention and cooperation.
Hormat kami /Regards,
PT Bundamedik Tbk
bmhs
since 1973
PT Bundamedik Tbk
Mesha Rizal Sini
5 . President Director
Tembusan/copy :
- Deputi Konnisioner Pengawas Pasar Modal II OJK — via Sistem Pelaporan Elektronik OJK; /
OJK Deputy Commissioner for Capital Market Supervision ll — via the OJK Electronic Reporting System;
- Direksi PT Bursa Efek Indonesia; / Directors of PT Bursa Efek Indonesia
- PT Kustodian Sentral Efek Indonesia; / Indonesian Central Securities Depository
- PT Datindo Entrycom selaku Biro Administrasi Efek; dan /PT Datindo Entrycom as Securities Administration Bureau
- Dewan Komisaris dan Direksi Perseroan /Board of Commissioners and Board of Directors of the Company.
PT Bundamedik Tbk
11. Teuku Cik Ditiro No. 28
Menteng-Jakarta Pusat 10350, Indonesia
t.+62 21 3192 3344 a +62 21 3190 5915 19 www.bmhs.co.id
From Embryo Throughout Life
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.